Royal Bank of Canada’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.3M | Buy |
|
|||||
|
2025
Q1 | $45.2M | Buy |
|
|||||
|
2024
Q4 | $37.7M | Sell |
|
|||||
|
2024
Q3 | $66.5M | Sell |
|
|||||
|
2024
Q2 | $91.7M | Sell |
|
|||||
|
2024
Q1 | $87M | Buy |
|
|||||
|
2023
Q4 | $96.8M | Buy |
|
|||||
|
2023
Q3 | $78.8M | Sell |
|
|||||
|
2023
Q2 | $100M | Buy |
|
|||||
|
2023
Q1 | $79.8M | Sell |
|
|||||
|
2022
Q4 | $106M | Buy |
|
|||||
|
2022
Q3 | $67.4M | Sell |
|
|||||
|
2022
Q2 | $60.3M | Buy |
|
|||||
|
2022
Q1 | $55.2M | Sell |
|
|||||
|
2021
Q4 | $67.2M | Sell |
|
|||||
|
2021
Q3 | $82.4M | Sell |
|
|||||
|
2021
Q2 | $134M | Buy |
|
|||||
|
2021
Q1 | $98.4M | Sell |
|
|||||
|
2020
Q4 | $92.8M | Sell |
|
|||||
|
2020
Q3 | $119M | Buy |
|
|||||
|
2020
Q2 | $94.5M | Buy |
|
|||||
|
2020
Q1 | $94.1M | Sell |
|
|||||
|
2019
Q4 | $105M | Sell |
|
|||||
|
2019
Q3 | $85.4M | Buy |
|
|||||
|
2019
Q2 | $69.2M | Sell |
|
|||||
|
2019
Q1 | $90.5M | Sell |
|
|||||
|
2018
Q4 | $120M | Sell |
|
|||||
|
2018
Q3 | $158M | Sell |
|
|||||
|
2018
Q2 | $147M | Sell |
|
|||||
|
2018
Q1 | $177M | Buy |
|
|||||
|
2017
Q4 | $111M | Buy |
|
|||||
|
2017
Q3 | $94.1M | Buy |
|
|||||
|
2017
Q2 | $79.3M | Sell |
|
|||||
|
2017
Q1 | $95.5M | Sell |
|
|||||
|
2016
Q4 | $136M | Buy |
|
|||||
|
2016
Q3 | $117M | Buy |
|
|||||
|
2016
Q2 | $69.7M | Sell |
|
|||||
|
2016
Q1 | $78M | Sell |
|
|||||
|
2015
Q4 | $108M | Buy |
|
|||||
|
2015
Q3 | $67.6M | Sell |
|
|||||
|
2015
Q2 | $127M | Buy |
|
|||||
|
2015
Q1 | $107M | Sell |
|
|||||
|
2014
Q4 | $110M | Buy |
|
|||||
|
2014
Q3 | $96.5M | Buy |
|
|||||
|
2014
Q2 | $73.8M | Sell |
|
|||||
|
2014
Q1 | $74.5M | Sell |
|
|||||
|
2013
Q4 | $71.1M | Buy |
|
|||||
|
2013
Q3 | $49.8M | Sell |
|
|||||
|
2013
Q2 | $73.3M | Buy |
|